Black lung disease market players and analysis by type, by diagnosis, by treatment, by end-user– forecast till 2030. The global black lung disease is driven by factors like rising mining activity, rising black lung disease prevalence, rising research and development costs, and rising healthcare costs. The market growth is expected to be constrained throughout the projected period by factors like lack of knowledge, a lack of available medical treatment choices, expensive surgical therapeutic costs for lung transplantation, and stem cell therapy.
The global black lung disease market is expected to grow at an approximate CAGR of 13.80% during the forecast period.
Key Players
The key players for the global black lung disease market are Boehringer Ingelheim International GmbH (Germany), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), AstraZeneca (U.K), Koninklijke Philips N.V. (The Netherlands), GENERAL ELECTRIC (U.S.), Siemens AG (Germany), TOSHIBA CORPORATION (Japan), Medtronic (U.S.), and others.
Segmentation
The global black lung disease market is segmented by the type, diagnosis, treatment and end user.
On the basis of the type, the market is segmented into simple coal worker’s pneumoconiosis, complicated coal worker’s pneumoconiosis, and others.
On the basis of the diagnosis, the market is segmented into biopsy, imaging, full blood count, pulmonary/lung function tests, physical examination, and others. The imaging segment is segmented into CT, X-ray, and others.
On the basis of the treatment, the market is segmented into oxygen therapy, bronchodilators, lung transplant, stem cell therapy, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, research organizations & academic institutes, diagnostic centers & labs, and others.
Regional Analysis
The Americas dominate the global black lung disease market. Factors such as a well-developed healthcare sector, huge patient population, increasing healthcare expenditure and presence of the key players within the region drives the market growth. Europe stands second in the global black lung disease market owing to rising government support, huge patient population, and rising healthcare expenditure. Regionally, the European black lung disease market is segmented into Western Europe and Eastern Europe. Western Europe is estimated to lead the regional market due to the presence of developed within the region.
Asia Pacific is the fastest growing region for the black lung disease market. due to the presence of a huge patient population, continuously developing healthcare sector, and rising healthcare expenditure. The Middle East & Africa has the least share in the global black lung disease market owing to the presence of poor economies, lack of a developed healthcare sector, stringent government policies, and lack of awareness for the disease, restrains the market growth, especially within the Africa region. A majority of the market of this region is held by the Middle East due to presence of developed economies within the region like Dubai, Kuwait, Saudi Arabia, and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
